+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Marketing Authorization"

From
Orexin Receptor Type 1 - Drugs In Development, 2021 - Product Thumbnail Image

Orexin Receptor Type 1 - Drugs In Development, 2021

  • Report
  • July 2021
  • 85 Pages
  • Global
From
From
From
From
Smallpox (Infectious Disease) - Drugs in Development, 2021 - Product Thumbnail Image

Smallpox (Infectious Disease) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
From
From
Pharmaceutical Drug Registration in China - Webinar (Recorded) - Product Thumbnail Image

Pharmaceutical Drug Registration in China - Webinar (Recorded)

  • Webinar
  • October 2019
  • 90 Minutes
  • China
From
New Drug Approval in the European Union - Product Thumbnail Image

New Drug Approval in the European Union

  • Book
  • June 2002
  • 356 Pages
  • Europe
Loading Indicator

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards. Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more